Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
    March 2018
  1. FEI HR, Li ZJ, Ying-Zhang, Yue-Liu, et al
    HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
    Gene. 2018;647:39-47.
    >> Share

  2. RAGHAVAN S, Venkatraman G, Rayala SK
    Cloning and functional characterization of human Pak1 promoter by steroid hormones.
    Gene. 2018;646:120-128.
    >> Share

    February 2018
  3. GHALI R, Al-Mutawa MA, Al-Ansari AK, Zaied S, et al
    Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Gene. 2018 Feb 4. pii: S0378-1119(18)30140-9. doi: 10.1016/j.gene.2018.
    >> Share

  4. LI XP, Lan JY, Liu DQ, Zhou H, et al
    OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Gene. 2018 Feb 1. pii: S0378-1119(18)30121-5. doi: 10.1016/j.gene.2018.
    >> Share

    January 2018
  5. CHEN J, Jiang Y, Zhou J, Liu S, et al
    Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
    Gene. 2018 Jan 24. pii: S0378-1119(18)30085-4. doi: 10.1016/j.gene.2018.
    >> Share

  6. DANESH H, Hashemi M, Bizhani F, Hashemi SM, et al
    Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population.
    Gene. 2018 Jan 6. pii: S0378-1119(18)30032-5. doi: 10.1016/j.gene.2018.
    >> Share

    December 2017
  7. KAR S, Patra SK
    Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Gene. 2017 Dec 1. pii: S0378-1119(17)31043-0. doi: 10.1016/j.gene.2017.
    >> Share

    November 2017
  8. KLASSEN LMB, Chequin A, Manica GCM, Biembengut IV, et al
    MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
    Gene. 2017 Nov 18. pii: S0378-1119(17)31018-1. doi: 10.1016/j.gene.2017.
    >> Share

  9. PENG R, Luo C, Guo Q, Cao J, et al
    Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
    Gene. 2017 Nov 13. pii: S0378-1119(17)30956-3. doi: 10.1016/j.gene.2017.
    >> Share

    October 2017
  10. JANAKI RAMAIAH M, Naushad SM, Lavanya PON, Gayatri A, et al
    Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Gene. 2017 Oct 13. pii: S0378-1119(17)30831-4. doi: 10.1016/j.gene.2017.
    >> Share

  11. ZHOU L, Gao HF, Liu DS, Feng JY, et al
    Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
    Gene. 2017 Oct 9. pii: S0378-1119(17)30833-8. doi: 10.1016/j.gene.2017.
    >> Share

    September 2017
  12. LAHIRI DK, Maloney B, Sambamurti K
    When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
    Gene. 2017 Sep 6. pii: S0378-1119(17)30646-7. doi: 10.1016/j.gene.2017.
    >> Share

    August 2017
  13. YI Y, Huang C, Zhang Y, Tian S, et al
    Exploring a common mechanism of alcohol-induced deregulation of RNA Pol III genes in liver and breast cells.
    Gene. 2017;626:309-318.
    >> Share

    July 2017
  14. BELYAVSKAYA VA, Prudnikova TY, Domanitskaya NV, Litviakov NV, et al
    GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.
    Gene. 2017 Jul 19. pii: S0378-1119(17)30578-4. doi: 10.1016/j.gene.2017.
    >> Share

    June 2017
  15. ZHOU J, Hang D, Jiang Y, Chen J, et al
    Evaluation of genetic variants in autophagy pathway genes as prognostic biomarkers for breast cancer.
    Gene. 2017 Jun 29. pii: S0378-1119(17)30503-6. doi: 10.1016/j.gene.2017.
    >> Share

  16. YELKEN BO, Balci T, Susluer SY, Kayabasi C, et al
    The effect of tomatine on metastasis related matrix metalloproteinase (MMP) activities in breast cancer cell model.
    Gene. 2017 Jun 29. pii: S0378-1119(17)30505-X. doi: 10.1016/j.gene.2017.
    >> Share

    April 2017
  17. YANG SJ, Wang DD, Li J, Xu HZ, et al
    Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.
    Gene. 2017 Apr 21. pii: S0378-1119(17)30283-4. doi: 10.1016/j.gene.2017.
    >> Share

  18. SHUI Y, Yu X, Duan R, Bao Q, et al
    miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma.
    Gene. 2017;609:80-87.
    >> Share

  19. ZHOU S, Li J, Xu H, Zhang S, et al
    Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
    Gene. 2017 Apr 18. pii: S0378-1119(17)30277-9. doi: 10.1016/j.gene.2017.
    >> Share

  20. SULTANA R, Kataki AC, Borthakur BB, Basumatary TK, et al
    Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
    Gene. 2017 Apr 14. pii: S0378-1119(17)30272-X. doi: 10.1016/j.gene.2017.
    >> Share

  21. HUANG H, Li C, Ren G
    Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
    Gene. 2017 Apr 12. pii: S0378-1119(17)30246-9. doi: 10.1016/j.gene.2017.
    >> Share

    March 2017
  22. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
    Corrigendum to "Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer" [Gene 608C (2017) 73-78].
    Gene. 2017 Mar 28. pii: S0378-1119(17)30210-X. doi: 10.1016/j.gene.2017.
    >> Share

  23. ZHANG K, Wang YW, Wang YY, Song Y, et al
    Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Gene. 2017 Mar 27. pii: S0378-1119(17)30218-4. doi: 10.1016/j.gene.2017.
    >> Share

  24. MANJEGOWDA MC, Gupta PS, Limaye AM
    Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Gene. 2017 Mar 7. pii: S0378-1119(17)30141-5. doi: 10.1016/j.gene.2017.
    >> Share

    February 2017
  25. MAURO JA, Yavorski JM, Blanck G
    Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genes.
    Gene. 2017 Feb 28. pii: S0378-1119(17)30126-9. doi: 10.1016/j.gene.2017.
    >> Share

  26. DEHGHAN Z, Sadeghi S, Tabatabaeian H, Ghaedi K, et al
    ESR1 single nucleotide polymorphism rs1062577 (c.*3804T>A) alters the susceptibility of breast cancer risk in Iranian population.
    Gene. 2017 Feb 16. pii: S0378-1119(17)30105-1. doi: 10.1016/j.gene.2017.
    >> Share

    January 2017
  27. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
    Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.
    Gene. 2017 Jan 18. pii: S0378-1119(17)30032-X. doi: 10.1016/j.gene.2017.
    >> Share

    December 2016
  28. EL HADI H, Abdellaoui-Maane I, Kottwitz D, El Amrani M, et al
    Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    Gene. 2016 Dec 28. pii: S0378-1119(16)31027-7. doi: 10.1016/j.gene.2016.
    >> Share

  29. PRONINA IV, Loginov VI, Burdennyy AM, Fridman MV, et al
    DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Gene. 2016 Dec 17. pii: S0378-1119(16)31007-1. doi: 10.1016/j.gene.2016.
    >> Share

  30. LI HC, Chen YF, Feng W, Cai H, et al
    Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
    Gene. 2016 Dec 1. pii: S0378-1119(16)30952-0. doi: 10.1016/j.gene.2016.
    >> Share

    November 2016
  31. YANG F, Luo LJ, Zhang L, Wang DD, et al
    MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.
    Gene. 2016 Nov 29. pii: S0378-1119(16)30946-5. doi: 10.1016/j.gene.2016.
    >> Share

    October 2016
  32. SHEN H, Wang D, Li L, Yang S, et al
    MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Gene. 2016 Oct 13. pii: S0378-1119(16)30820-4. doi: 10.1016/j.gene.2016.
    >> Share

  33. CHEN X, Lu P, Wang DD, Yang SJ, et al
    The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.
    Gene. 2016 Oct 13. pii: S0378-1119(16)30818-6. doi: 10.1016/j.gene.2016.
    >> Share

  34. ZHANG Q, Liang Z, Gao Y, Teng M, et al
    Differentially expressed mitochondrial genes in breast cancer cells: Potential new targets for anti-cancer therapies.
    Gene. 2016 Oct 6. pii: S0378-1119(16)30799-5. doi: 10.1016/j.gene.2016.
    >> Share

    September 2016
  35. SUN Z, Wu Z, Zhang F, Guo Q, et al
    PRAME is critical for breast cancer growth and metastasis.
    Gene. 2016 Sep 12. pii: S0378-1119(16)30732-6. doi: 10.1016/j.gene.2016.
    >> Share

  36. LUO LJ, Yang F, Ding JJ, Yan DL, et al
    MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Gene. 2016 Sep 1. pii: S0378-1119(16)30702-8. doi: 10.1016/j.gene.2016.
    >> Share

    August 2016
  37. SHEN H, Li L, Yang S, Wang D, et al
    MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3beta signaling pathway.
    Gene. 2016 Aug 11. pii: S0378-1119(16)30633-3. doi: 10.1016/j.gene.2016.
    >> Share

  38. HOU L, Chen M, Wang M, Cui X, et al
    Systematic analyses of key genes and pathways in the development of invasive breast cancer.
    Gene. 2016 Aug 6. pii: S0378-1119(16)30624-2. doi: 10.1016/j.gene.2016.
    >> Share

  39. JIA Z, Liu Y, Gao Q, Han Y, et al
    miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
    Gene. 2016 Aug 6. pii: S0378-1119(16)30631-X. doi: 10.1016/j.gene.2016.
    >> Share

    July 2016
  40. YANG F, Liu YH, Dong SY, Yao ZH, et al
    Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer.
    Gene. 2016 Jul 2. pii: S0378-1119(16)30528-5. doi: 10.1016/j.gene.2016.
    >> Share

  41. SAREDDY GR, Vadlamudi RK
    PELP1: Structure, biological function and clinical significance.
    Gene. 2016;585:128-34.
    >> Share

    June 2016
  42. YERMACHENKO A, VolodymyrDvornyk
    UGT2B4 previously implicated in the risk of breast cancer is associated with menarche timing in ukrainian females.
    Gene. 2016 Jun 6. pii: S0378-1119(16)30479-6. doi: 10.1016/j.gene.2016.
    >> Share

  43. WANG DD, Li J, Sha HH, Chen X, et al
    miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27 expression.
    Gene. 2016 Jun 6. pii: S0378-1119(16)30477-2. doi: 10.1016/j.gene.2016.
    >> Share

    May 2016
  44. SEVINC ED, Cecener G, Ak S, Tunca B, et al
    Expression and Clinical Significance of miRNAs That May Be Associated with the FHIT Gene in Breast Cancer.
    Gene. 2016 May 25. pii: S0378-1119(16)30410-3. doi: 10.1016/j.gene.2016.
    >> Share

  45. DEB P, Bhan A, Hussain I, Ansari KI, et al
    Endocrine disrupting chemical, bisphenol-A, induces breast cancer associated gene HOXB9 expression in vitro and in vivo.
    Gene. 2016 May 12. pii: S0378-1119(16)30367-5. doi: 10.1016/j.gene.2016.
    >> Share

  46. KARA M, Kaplan M, Bozgeyik I, Ozcan O, et al
    Mtus1 Tumor Suppressor And Its Mirna Regulators In Fibroadenoma And Breast Cancer.
    Gene. 2016 May 4. pii: S0378-1119(16)30363-8. doi: 10.1016/j.gene.2016.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016